About
Contract Biologics & Related
Areas of Focus
Categories
Contract ManufacturingContract ManufacturingContract ManufacturingContract ManufacturingAustria
Team (11)
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
4
As Collaborator
1
Total Enrollment
497
By Phase
PHASE1: 1PHASE2: 3PHASE1/PHASE2: 1
By Status
COMPLETED: 5
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Today
Hover over trial bars to see details
Recent Trials
NCT04912076Collaborator
S.C. Immunotherapy With BM41 in Patients With Allergic Rhino-conjunctivitis Caused by Birch Pollen
PHASE1Completed
47 participants
Started: Sep 17, 2018 · Completed: Mar 22, 2019
NCT02643641Lead Sponsor
Effect of Different Pre-seasonal BM32 Dosings on the Induction of a Protective Immune Response
PHASE2Completed
130 participants
Started: Jan 31, 2016 · Completed: Jan 31, 2017
NCT01538979Lead Sponsor
Phase II Study of Grass Pollen Allergy Vaccine BM32
PHASE2Completed
181 participants
Started: Mar 31, 2012 · Completed: Mar 31, 2015
NCT01445002Lead Sponsor
Safety and Dose Finding Trial of BM32 in Subjects Suffering From Grass Pollen Allergy
PHASE2Completed
79 participants
Started: Oct 31, 2011 · Completed: Oct 31, 2012
NCT01350635Lead Sponsor
Skin Test Study of BM32
PHASE1/PHASE2Completed
60 participants
Started: May 31, 2011 · Completed: Sep 30, 2011
Locations (1)
Headquarters
Vienna, Austria
Map
Loading map...